A new generation of brain-computer interface company ladder medical received hundreds of millions of yuan in Series A financing.

Yiou Health was informed on the 30th that Ladder Medical, a cutting-edge technology company focusing on the research and development of the underlying technology of the next-generation brain-computer interface, recently announced the completion of several hundred million yuan of Series A financing, which was jointly led by Aobo Capital and Yuanhe Origin. This round of financing will continue to be used for system research and development and team expansion, and continue to maintain the company's leading position in the field of implantable brain-computer interface.

Ladder medical care was founded in 2021 by several top scientists in the field of brain-computer interface and neuroscience. At the same time, the company announced that the team has achieved record results in various animal experiments, and its ultra-flexible electrode technology has realized the first long-term implantation of sober macaques in vivo. At the same time, the company's clinical research experiments on various nervous system diseases are also advancing rapidly.

As a pioneer of the new generation of implantable brain-computer interface, Step Medical divides the realization of brain-computer interface into three main links: one is to develop ultra-flexible neural electrodes with Qualcomm quantity, the other is to develop the whole system (implanted equipment, signal acquisition and decoding, intelligent terminal, etc.), and the third is to carry out large animal experiments and clinical research.